During the past decade, Department of Internal Medicine III, City Hospital Frankfurt am Main - Höchst conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Department of Internal Medicine III, City Hospital Frankfurt am Main - Höchst" are "Acute Myeloid Leukemia" (2 trials) and "Leukemia, Myeloid, Acute" (1 trials). Many other conditions were trialed in "Department of Internal Medicine III, City Hospital Frankfurt am Main - Höchst" in a lesser frequency.

Most popular intervention types in "Department of Internal Medicine III, City Hospital Frankfurt am Main - Höchst" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Cytarabine" (3 trials), "All-trans retinoic acid" (2 trials), "Idarubicin" (2 trials), "Mitoxantrone" (2 trials) and "All-trans-Retinoid Acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Internal Medicine III, City Hospital Frankfurt am Main - Höchst" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Department of Internal Medicine III, City Hospital Frankfurt am Main - Höchst". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Department of Internal Medicine III, City Hospital Frankfurt am Main - Höchst, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Internal Medicine III, City Hospital Frankfurt am Main - Höchst, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".